Clinical Trial Update: Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial compares adjuvant oxaliplatin plus S-1 versus docetaxel plus S-1 for stage III gastric cancer; recruitment is ongoing at Ruijin Hospi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Ruijin Hospital | Conditions: Gastric Cancer (GC), Adjuvant Chemotherapy | Phase 3 | Status: RECRUITING